PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-7.52%
Both yoy net incomes decline, with AVGO at -16.62%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.02%
D&A growth well above AVGO's 1.66%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-133.25%
Negative yoy deferred tax while AVGO stands at 149.74%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
2742.05%
SBC growth well above AVGO's 31.11%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-203.72%
Negative yoy working capital usage while AVGO is 0.84%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
9.47%
AR growth while AVGO is negative at -58.81%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-392.66%
Both reduce yoy inventory, with AVGO at -49.54%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
4015.99%
AP growth well above AVGO's 122.19%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-176.67%
Both reduce yoy usage, with AVGO at -55.52%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-29.49%
Both negative yoy, with AVGO at -16.42%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-77.64%
Negative yoy CFO while AVGO is 9.32%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
11.85%
CapEx growth well above AVGO's 1.39%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-452.52%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
40.63%
Some yoy expansion while AVGO is negative at -73.68%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-87.51%
Both yoy lines are negative, with AVGO at -34.62%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-452.52%
We reduce yoy other investing while AVGO is 2940.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1371.68%
We reduce yoy invests while AVGO stands at 170.68%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
288.99%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.